MeadowBrook Investment Advisors LLC Sells 3,797 Shares of CVS Health Co. (NYSE:CVS)

MeadowBrook Investment Advisors LLC trimmed its position in CVS Health Co. (NYSE:CVS) by 26.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,814 shares of the pharmacy operator’s stock after selling 3,797 shares during the period. MeadowBrook Investment Advisors LLC’s holdings in CVS Health were worth $485,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. bought a new stake in CVS Health in the 3rd quarter valued at about $25,000. Ridgewood Investments LLC boosted its stake in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC acquired a new position in CVS Health during the 4th quarter valued at about $28,000. Livelsberger Financial Advisory acquired a new position in CVS Health during the 3rd quarter valued at about $31,000. Finally, Legacy Investment Solutions LLC acquired a new position in CVS Health during the 3rd quarter valued at about $31,000. 80.66% of the stock is owned by institutional investors.

CVS Health Price Performance

Shares of NYSE CVS opened at $55.01 on Wednesday. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a 50 day simple moving average of $50.69 and a two-hundred day simple moving average of $55.95. The company has a market capitalization of $69.23 billion, a price-to-earnings ratio of 13.96, a P/E/G ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.84%. CVS Health’s dividend payout ratio (DPR) is 67.51%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CVS. Edward Jones upgraded CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Mizuho lowered their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. Evercore ISI boosted their target price on shares of CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Finally, Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $67.78.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.